532 research outputs found
The Effect of LXR Activators on AP-1 Proteins in Keratinocytes
Oxysterols, via activation of liver X receptor (LXR), regulate keratinocyte differentiation by stimulating transglutaminase cross-linking of several constituent proteins leading to the formation of the cornified envelope. We previously reported that oxysterols increase the expression of one of these cross-linked proteins, involucrin, and that this effect can be abolished by mutations of the distal activator protein (AP)-1 response element in the involucrin promoter. Furthermore, oxysterols increase AP-1 binding in an electrophoretic gel mobility shift assay and increase the expression of an AP-1 reporter. In this study, we describe the individual components of the AP-1 complex that are involved in the oxysterol-mediated AP-1 activation and stimulation of keratinocyte differentiation. We identified Fra-1 within the AP-1 DNA binding complex by supershift analysis of nuclear extracts from oxysterol-treated, cultured keratinocytes and confirmed that oxysterol treatment increased the levels of Fra-1 by western blot analysis. Additionally, on Western and Northern analysis, oxysterol treatment increased two other AP-1 proteins, Jun-D and c-Fos, whereas Fra-2, Jun-B, and c-Jun were not changed. Similar alterations in AP-1 proteins occurred when 25-OH-cholesterol or non-steroidal LXR agonists (GW3965, TO-901317) were used. These results indicate that oxysterols induce specific AP-1 proteins, thereby activating involucrin, one of the genes required for epidermal differentiation
Meconema thalassinum (Orthoptera: Tettigoniidae), a foreign katydid established in British Columbia
Surface design for immobilization of an antimicrobial peptide mimic for efficient antiâbiofouling
Microbial surface attachment negatively impacts a wide range of devices from water purification membranes to biomedical implants. Mimics of antimicrobial peptides (AMPs) constituted from poly(Nâsubstituted glycine) "peptoids" are of great interest as they resist proteolysis and can inhibit a wide spectrum of microbes. We investigate how terminal modification of a peptoid AMPâmimic and its surface immobilization affect antimicrobial activity. We also demonstrate a convenient surface modification scheme for enabling alkyneâazide "click" coupling on aminoâfunctionalized surfaces. Our results verified that the Nâ and Câterminal peptoid structures are not required for antimicrobial activity. Moreover, our peptoid immobilization density and choice of PEG tether resulted in a "volumetric" spatial separation between AMPs that, compared to past studies, enabled the highest AMP surface activity relative to bacterial attachment. Our analysis suggests the importance of spatial flexibility for membrane activity and that AMP separation may be a controlling parameter for optimizing surface antiâbiofouling
The Impact of Cluster Structure and Dynamical State on Scatter in the Sunyaev-Zel'dovich Flux-Mass Relation
Cosmological constraints from cluster surveys rely on accurate mass estimates
from the mass-observable relations. In order to avoid systematic biases and
reduce uncertainties, we study the form and physical origin of the intrinsic
scatter about the mean Sunyaev-Zel'dovich (SZ) flux-mass relation using a
hydrodynamical simulation of galaxy cluster formation. We examine the
assumption of lognormal scatter and detect non-negligible positive skewness and
kurtosis (> 0.5) for a wide range of limiting masses and redshifts. These
higher-order moments should be included in the parametrization of scatter in
order not to bias cosmological constraints. We investigate the sources of the
scatter by correlating it with measures of cluster morphology, halo
concentration, and dynamical state, and we quantify the individual contribution
from each source. We find that statistically the impact of dynamical state is
weak, so the selection bias due to mergers is negligible. On the other hand,
there is a strong correlation between the scatter and halo concentration, which
can be used to reduce the scatter significantly (from 12.07% to 7.34% or by
~40% for clusters at z = 0). We also show that a cross-calibration by combining
information from X-ray followups can be used to reduce the scatter in the
flux-mass relation and also identify outliers in both X-ray and SZ cluster
surveys.Comment: 14 pages, 12 figures; accepted for publication in Ap
A Pilot Study (SWOG S0429) of Weekly Cetuximab and Chest Radiotherapy for Poor-Risk Stage III Non-Small Cell Lung Cancer
PURPOSE: Stage III non-small cell lung cancer (NSCLC) patients with poor performance status (PS) or co-morbidities are often not candidates for standard chemoradiotherapy (chemoRT) due to poor tolerance to treatments. A pilot study for poor-risk stage III NSCLC patients was conducted combining cetuximab, a chimeric monoclonal antibody targeting epidermal growth factor receptor (EGFR), with chest radiation (RT).
METHODS: Stage III NSCLC patients with Zubrod PS 2, or Zubrod PS 0-1 with poor pulmonary function and co-morbidities prohibiting chemoRT were eligible. A loading dose of cetuximab (400 mg/m(2)) was delivered week 1, followed by weekly cetuximab (250 mg/m(2))/RT to 64.8 Gy in 1.8 Gy daily fractions, and maintenance weekly cetuximab (250 mg/m(2)) for 2 years or until disease progression. H-score for EGFR protein expression was conducted in available tumors.
RESULTS: Twenty-four patients were enrolled. Twenty-two were assessed for outcome and toxicity. Median survival was 14 months and median progression-free survival was 8 months. The response rate was 47% and disease control rate was 74%. Toxicity assessment revealed 22.7% overall \u3e /=Grade 3 non-hematologic toxicities. Grade 3 esophagitis was observed in one patient (5%). The skin reactions were mostly Grade 1 or 2 except two of 22 (9%) had Grade 3 acne and one of 22 (5%) had Grade 3 radiation skin burn. Grade 3-4 hypomagnesemia was seen in four (18%) patients. One patient (5%) had elevated cardiac troponin and pulmonary emboli. H-score did not reveal prognostic significance. An initially planned second cohort of the study did not commence due to slow accrual, which would have added weekly docetaxel to cetuximab/RT after completion of the first cohort of patients.
CONCLUSION: Concurrent weekly cetuximab/chest RT followed by maintenance cetuximab for poor-risk stage III NSCLC was well tolerated. Further studies with larger sample sizes will be useful to establish the optimal therapeutic ratio of this regimen
Human Cytomegalovirus Long Non-coding RNA1.2 Suppresses Extracellular Release of the Pro-inflammatory Cytokine IL-6 by Blocking NF-ÎșB Activation.
Long non-coding RNAs (lncRNAs) are transcripts of >200 nucleotides that are not translated into functional proteins. Cellular lncRNAs have been shown to act as regulators by interacting with target nucleic acids or proteins and modulating their activities. We investigated the role of RNA1.2, which is one of four major lncRNAs expressed by human cytomegalovirus (HCMV), by comparing the properties of parental virus in vitro with those of deletion mutants lacking either most of the RNA1.2 gene or only the TATA element of the promoter. In comparison with parental virus, these mutants exhibited no growth defects and minimal differences in viral gene expression in human fibroblasts. In contrast, 76 cellular genes were consistently up- or down-regulated by the mutants at both the RNA and protein levels at 72 h after infection. Differential expression of the gene most highly upregulated by the mutants (Tumor protein p63-regulated gene 1-like protein; TPRG1L) was confirmed at both levels by RT-PCR and immunoblotting. Consistent with the known ability of TPRG1L to upregulate IL-6 expression via NF-ÎșB stimulation, RNA1.2 mutant-infected fibroblasts were observed to upregulate IL-6 in addition to TPRG1L. Comparable surface expression of TNF receptors and responsiveness to TNF-α in cells infected by the parental and mutant viruses indicated that activation of signaling by TNF-α is not involved in upregulation of IL-6 by the mutants. In contrast, inhibition of NF-ÎșB activity and knockdown of TPRG1L expression reduced the extracellular release of IL-6 by RNA1.2 mutant-infected cells, thus demonstrating that upregulation of TPRG1L activates NF-ÎșB. The levels of MCP-1 and CXCL1 transcripts were also increased in RNA1.2 mutant-infected cells, further demonstrating the presence of active NF-ÎșB signaling. These results suggest that RNA1.2 plays a role in manipulating intrinsic NF-ÎșB-dependent cytokine and chemokine release during HCMV infection, thereby impacting downstream immune responses
The Robo-AO-2 facility for rapid visible/near-infrared AO imaging and the demonstration of hybrid techniques
We are building a next-generation laser adaptive optics system, Robo-AO-2,
for the UH 2.2-m telescope that will deliver robotic, diffraction-limited
observations at visible and near-infrared wavelengths in unprecedented numbers.
The superior Maunakea observing site, expanded spectral range and rapid
response to high-priority events represent a significant advance over the
prototype. Robo-AO-2 will include a new reconfigurable natural guide star
sensor for exquisite wavefront correction on bright targets and the
demonstration of potentially transformative hybrid AO techniques that promise
to extend the faintness limit on current and future exoplanet adaptive optics
systems.Comment: 15 page
HIV non-B subtype distribution: emerging trends and risk factors for imported and local infections newly diagnosed in South Australia
Monitoring HIV subtype distribution is important for understanding transmission dynamics. Subtype B has
historically been dominant in Australia, but in recent years new clades have appeared. Since 2000, clade data
have been collected as part of HIV surveillance in South Australia. The aim of this study was to evaluate the
prevalence of and risk factors for HIV-1 non-B subtypes. The study population was composed of newly diagnosed,
genotyped HIV subjects in South Australia between 2000 and 2010. We analyzed time trends and subtype
patterns in this cohort; notification data were aggregated into three time periods (2000â2003, 2004â2006, and
2007â2010). Main outcome measures were number of new non-B infections by year, exposure route, and other
demographic characteristics. There were 513 new HIV diagnoses; 425 had information on subtype. The majority
(262/425) were in men who have sex with men (MSM), predominantly subtype B and acquired in Australia.
Infections acquired in Australia decreased from 77% (2000â2003) to 64% (2007â2010) ( p = 0.007) and correspondingly
the proportion of subtype B declined from 85% to 68% ( p = 0.002). Non-B infections were predominantly
(83%) heterosexual contacts, mostly acquired overseas (74%). The majority (68%) of non-B patients
were born outside of Australia. There was a non-significant increase from 1.6% to 4.2% in the proportion of
locally transmitted non-B cases (p = 0.3). Three non-B subtypes and two circulating recombinant forms (CRFs)
were identified: CRF_AE (n = 41), C (n = 36), CRF_AG (n = 13), A (n = 9), and D (n = 2). There has been a substantial
increase over the past decade in diagnosed non-B infections, primarily through cases acquired overseas
Separation from mechanical ventilation and survival after spinal cord injury: a systematic review and meta-analysis
Abstract Background Prolonged need for mechanical ventilation greatly impacts life expectancy of patients after spinal cord injury (SCI). Weaning outcomes have never been systematically assessed. In this systematic review and meta-analysis, we aimed to investigate the probability of weaning success, duration of mechanical ventilation, mortality, and their predictors in mechanically ventilated patients with SCI. Methods We searched six databases from inception until August 2021 for randomized-controlled trials and observational studies enrolling adult patients (â„â16Â years) with SCI from any cause requiring mechanical ventilation. Titles and abstracts were screened independently by two reviewers. Full texts of the identified articles were then assessed for eligibility. Data were extracted independently and in duplicate by pairs of authors, using a standardized data collection form. Synthetic results are reported as meta-analytic means and proportions, based on random effects models. Results Thirty-nine studies (14,637 patients, mean age 43) were selected. Cervical lesions were predominant (12,717 patients had cervical lesions only, 1843 in association with other levelsâ lesions). Twenty-five studies were conducted in intensive care units (ICUs), 14 in rehabilitative settings. In ICU, the mean time from injury to hospitalization was 8Â h [95% CI 7â9], mean duration of mechanical ventilation 27Â days [20â34], probability of weaning success 63% [45â78] and mortality 8% [5â11]. Patients hospitalized in rehabilitation centres had a greater number of high-level lesions (C3 or above), were at 40Â days [29â51] from injury and were ventilated for a mean of 97Â days [65â128]; 82% [70â90] of them were successfully weaned, while mortality was 1% [0â19]. Conclusions Although our study highlights the lack of uniform definition of weaning success, of clear factors associated with weaning outcomes, and of high-level evidence to guide optimal weaning in patients with SCI, it shows that around two-thirds of mechanically ventilated patients can be weaned in ICU after SCI. A substantial gain in weaning success can be obtained during rehabilitation, with additional duration of stay but minimal increase in mortality. The study is registered with PROSPERO (CRD42020156788)
- âŠ